Baseline and periodic IGF-I , fasting glucose/HbA1c, lipids, liver function tests, and clinician-directed screening are typical
GHK-Cu is found in human plasma, where it is thought to promote a range of beneficial effects, including wound healing, antioxidant and anti-inflammatory
The best outcomes likely combine appropriate rehabilitation with peptide support when needed, not peptides alone
Please read below for some of the frequently asked questions ( FAQs ) I have received since FDA issued its Declaratory Order: 1
It seems that pharmacotherapy is starting to catch up with bariatric surgery with regards to initial weight loss, but long-term data are still not available
these changes are thought to be related to changes in cravings, hunger and fullness (Mozafarriun et al 2025)